Internal Medicine, Nephrology · Bay City, MI
NPI
1851647390
Since 2012
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
4818 W Professional Dr
Bay City, MI, 48706
Phone (989) 667-8872
Groups this clinician bills Medicare through
Medicare paid, 2024
$335K
4,321 services
Medicare patients, 2024
730
Average age 74
Drug cost, 2024
$984K
3,705 prescriptions
Company payments, 2025
$11K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Muwaffaq Salameh was code 99214 (office e&m - established), 996 times for 408 patients. In total Muwaffaq Salameh billed 4,321 services in 29 codes, and Medicare paid $335K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 996 | 408 | $69.60 | $69K |
| 99232 Hospital E&M - Subsequent | Facility | 726 | 195 | $64.07 | $47K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 494 | 317 | $13.43 | $6,635 |
| 99233 Hospital E&M - Subsequent | Facility | 305 | 103 | $96.53 | $29K |
| 99457 E&M - Miscellaneous | Office | 242 | 36 | $37.50 | $9,074 |
| 90966 ESRD Related Services (not dialysis) | Office | 214 | 35 | $249.16 | $53K |
| 99454 E&M - Miscellaneous | Office | 168 | 28 | $34.29 | $5,761 |
| 99458 E&M - Miscellaneous | Office | 154 | 28 | $30.58 | $4,709 |
| 99213 Office E&M - Established | Office | 143 | 117 | $64.71 | $9,254 |
| 99232 Hospital E&M - Subsequent | Office | 124 | 45 | $64.44 | $7,991 |
| 99223 Hospital E&M - Initial | Facility | 99 | 87 | $139.42 | $14K |
| 99222 Hospital E&M - Initial | Facility | 87 | 67 | $105.70 | $9,196 |
| 90961 ESRD Related Services (not dialysis) | Office | 82 | 14 | $248.93 | $20K |
| 99233 Hospital E&M - Subsequent | Office | 70 | 21 | $96.80 | $6,776 |
| 99203 Office E&M - New | Office | 68 | 68 | $77.40 | $5,263 |
By year: 2022 $421K for 5,684 services; 2023 $400K for 4,985 services; 2024 $335K for 4,321 services.
Medicare prescription drug claims, 2024
In 2024, the drug Muwaffaq Salameh prescribed most often to Medicare patients was Amlodipine Besylate, with 410 prescriptions and refills. In total Muwaffaq Salameh wrote 3,705 Medicare prescriptions that cost $984K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 410 | 1,146 | 159 | $3,059 |
| Hydralazine Hcl Generic | 322 | 816 | 120 | $6,090 |
| Farxiga Dapagliflozin Propanediol | 314 | 709 | 86 | $379K |
| Furosemide Generic | 295 | 745 | 104 | $2,145 |
| Losartan Potassium Generic | 219 | 568 | 76 | $2,552 |
| Metolazone Generic | 210 | 514 | 84 | $9,983 |
| Calcitriol Generic | 203 | 575 | 74 | $3,658 |
| Potassium Chloride Generic | 171 | 439 | 62 | $4,820 |
| Bumetanide Generic | 161 | 387 | 65 | $9,085 |
| Nifedipine Er Nifedipine | 145 | 342 | 40 | $3,715 |
| Torsemide Generic | 119 | 256 | 45 | $3,676 |
| Jardiance Empagliflozin | 117 | 303 | 38 | $168K |
| Lisinopril Generic | 77 | 227 | 36 | $871 |
| Spironolactone Generic | 68 | 192 | 28 | $760 |
| Tamsulosin Hcl Generic | 49 | 135 | 23 | $866 |
Brand drugs: 614 claims; generic drugs: 3,091 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Muwaffaq Salameh $11K ($11K in general payments such as food, travel and fees) from 13 companies. The largest payer was Akebia Therapeutics Inc with $10K.
| Company | Payments | Amount |
|---|---|---|
| Akebia Therapeutics Inc AKBA | 15 | $10K |
| Calliditas Therapeutics US Inc. | 11 | $236 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $199 |
| Amgen Inc. AMGN | 8 | $190 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $171 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $103 |
| Vantive US Healthcare LLC | 2 | $101 |
| Travere Therapeutics, Inc. TVTX | 4 | $101 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $32.37 |
| Novo Nordisk Inc NVO | 1 | $28.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.